During this week’s Dutch economic mission to the United Kingdom (led by the Netherlands Enterprise Agency (RVO), Dutch Ministry of Foreign Affairs, and the Dutch embassy in London), Oncode Institute, Oncode Accelerator and Cancer Research Horizons – the innovation arm of Cancer Research UK – took a significant step towards future collaboration with the signing of a joint Memorandum of Understanding (MoU).
Mark Krul, Chief Scientific Officer of Oncode Accelerator Foundation, commented on the significance of the MoU: “The signing of this Memorandum of Understanding with our sister organization Oncode Institute and Cancer Research Horizons is an important moment for Oncode Accelerator as we expand our international collaboration efforts. This agreement strengthens our commitment to accelerating the development of new cancer therapies by working collaboratively with other experts in the field.”
Read the whole story here.
Oncode Accelerator is continuing to explore similar partnerships across Europe and beyond, and interested parties are welcome to reach out to demonstrators@oncodeaccelerator.nl
All images by pbmedia.